The JMW healthcare & aesthetics regulatory risk guide 2026
The regulatory framework for the healthcare and aesthetics sector has been subject to many recent changes, and proposed future changes are on the horizon. For clinic owners, practitioners, prescribers and others within the industry, it is vital to stay up-to-date on your legal obligations and assess how these proposals could change them before they take effect. This is a key aspect of risk management for aesthetics businesses, and especially those that provide treatments that are not subject to oversight by the Care Quality Commission (CQC), the General Medical Council or another existing regulator.
Over the last few years, changes to how Botulinum toxin injections (Botox) were administered and regulated meant that many aesthetic practitioners had to overhaul their businesses, and the introduction of powers to allow the Secretary of State to license certain non-surgical cosmetic procedures has led to a period of uncertainty.
New proposals would restrict who can perform the most invasive cosmetic procedures in England and bring more providers under the CQC's oversight, which brings its own set of regulatory expectations. While the proposed licensing regime is not yet law, practitioners and businesses should expect some greater degree of regulation on many of the most common procedures to enter into force in the near future.
At JMW, our aesthetics sector solicitors specialise in advising treatment providers on their legal responsibilities and the regulatory requirements that apply based on the procedures they perform. Here, we explain the current regulatory framework for aesthetic medicine in 2026, proposals for non surgical cosmetic procedures and practical steps that aesthetic practitioners should take to maintain compliance. For an aesthetic medicine practice, the distinction between current duties and future regulation, and the timeline for proposed changes, are key factors in effectively managing business exposure.
What are the key changes affecting the aesthetics industry in 2026?
While no significant changes have been made to regulations in 2026, those of the past few years have begun to take effect in ways that have affected business operations. For those who are starting a business, it is important to understand the current regulatory landscape affecting the aesthetics industry. Although it has not yet entered into law, significant progress has also been made in the government's plans to regulate many more non-surgical cosmetic procedures and to introduce a new licensing scheme in the next few years.
Consent and age restrictions
The Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 makes it an offence in England to administer Botox or inject cosmetic fillers to someone under 18, subject to specified exceptions involving medical practitioners and regulated professionals acting under their direction. Businesses can also commit offences by arranging prohibited injections.
Practitioners must obtain informed consent before aesthetic procedures, by explaining the intended result, material risks and any alternatives beforehand. Practitioners should also remember that Botox is a prescription-only medicine which must be prescribed by an appropriately authorised prescriber. It may be administered by another suitably competent prescriber, subject to applicable legal and professional requirements.
Medicines, prescribing and product controls
Because Botulinum toxin is a prescription-only medicine, a suitably authorised prescriber must assess whether it is appropriate for each individual before supplying it. The General Medical Council's prescribing guidance requires doctors to physically examine patients before prescribing injectable cosmetic medicines, rather than issuing prescriptions remotely.
Other healthcare professionals must follow their regulator's prescribing standards. Aesthetic practitioners must use legitimate supply channels and safe storage procedures. Purchasing prescription-only medicines does not authorise their use or supply, and careful governance around issuing Botox is the best way for aesthetics businesses to maintain compliance and avoid regulatory scrutiny.
The Medicines and Healthcare products Regulatory Agency (MHRA) oversees medicines and medical devices, and errors in the provision of prescription-only medication (including supply chain irregularities or a failure to carry out due diligence in verifying the authenticity of products) could lead to significant regulatory risk from the MHRA.
Another restriction that applies to prescription-only medicines concerns advertising. Advertising prescription-only medicines to the public is prohibited under the Human Medicines Regulation 2012. Businesses that breach these restrictions may face regulatory enforcement action, including by the MHRA, as well as intervention by the Advertising Standards Authority.
The Health and Care Act 2022
Section 180 of the Health and Care Act 2022 gives the Secretary of State power to introduce a licensing scheme for specified non-surgical cosmetic procedures in England. It allows regulations requiring both individual practitioners and the premises used for cosmetic procedures to hold licences, and these considerations are currently being actively explored.
The act provides the legal framework for future licensing of non surgical procedures, and although no comprehensive national licensing scheme has been introduced, proposals are under consultation. Existing registration and licensing requirements will continue to apply, including relevant local authority requirements for certain skin-piercing activities.
Proposed restrictions and a licensing scheme for high-risk procedures
In August 2025, the UK Government committed to further regulation of the aesthetics sector. In October 2026, it published a consultation on high-risk cosmetic and wellbeing procedures that proposes a new regulatory framework for specified high risk procedures. The consultation is due to continue gathering insights into the proposal until January 2027.
Under the proposals, providers offering specified high-risk treatments would need to be registered with the CQC. Those procedures would be restricted to specified healthcare including doctors, dentists or nurses, midwives and pharmacists with independent prescribing qualifications. Cosmetic surgery would be restricted to doctors.
Following on from the introduction of the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021, the government has also proposed age restrictions on these treatments, with exceptions for NHS provision and treatment of medical conditions. The rules would see treatments limited to adults only, and breaches of this rule (or offering a regulated procedure without the necessary registration) could become criminal offences.
The Women and Equalities Committee called for faster intervention in September 2026, and aesthetics industry stakeholders should expect developments early in 2027. In the meantime, aesthetic practitioners should identify affected services to determine whether they will need to register or change their operations before the expected legislation takes effect.
How does the proposed licensing regime classify cosmetic procedures and aesthetic medicine?
The proposed licensing scheme for certain treatments and procedures is intended to make standards more consistent across the aesthetics industry. While the future licensing requirements for such procedures as chemical peels and fillers are yet to be formally determined, an earlier consultation was carried out in 2023 to categorise many different types of procedures according to the risk of harm.
After the government's 2023 consultation classified non-surgical cosmetic procedures by risk, it committed to licensing lower risk procedures and restricting the highest-risk treatments in August 2025. The categories remain a proposed framework rather than a comprehensive classification:
The following categories reflect the framework originally proposed in the 2023 consultation. They are not currently statutory classifications, and the procedures falling within each category remain subject to further regulatory decisions.
| Category | Examples | Proposal |
|---|---|---|
| Green: lower risk procedures | Microneedling, superficial chemical peels and certain light-based treatments | Practitioners could provide licensed treatments when they meet prescribed standards. |
| Amber: medium risk procedures | Botulinum toxin injections, some dermal fillers and medium-depth peels | Licensing would be required, with clinical oversight for eligible non-healthcare practitioners. |
| Red: high risk cosmetic procedures | Body-augmentation fillers, deep peels and other invasive treatments | Proposed to be restricted to specified healthcare professionals working for CQC-registered providers, subject to the final scope of the regulations. |
The October 2026 consultation revisits the red category, and asks for feedback on blood-based, laser and intravenous treatments, some of which could be more heavily restricted as a result.
What would practitioner and premises licensing involve?
Under the proposed licensing regime, local authorities would administer licences for specified green and amber procedures. The Health and Care Act 2022 permits the Secretary of State to introduce both personal and premises licences, under which practitioners would need to register with a relevant regulator and licensed premises would need to meet final hygiene and infection control requirements.
The CQC already regulates specified health and social care activities, although many aesthetic clinics that provide non surgical cosmetic treatments do not require registration. The regulator's current guidance on cosmetic surgery identifies procedures that require registration and distinguishes them from many standalone cosmetic injections and laser treatments.
Similarly, some professionals who provide treatment are already required to register with a regulator, including the General Medical Council for doctors; the Nursing and Midwifery Council for nurses and midwives; the General Dental Council for dental professionals; and the General Pharmaceutical Council for pharmacists and pharmacy premises.
Along with registration status, the proposed framework could specify qualifications, adequate training and indemnity standards, along with new insurance obligations, before licences could be granted. High risk procedures are being addressed separately through the proposed extension of CQC regulation. While requirements may differ between lower-risk clinics and invasive aesthetic medicine providers, it is best to work with an experienced aesthetic regulation solicitor to ensure that your business complies with any new regulations as they are introduced.
Registration with a professional regulator does not, itself, remove the requirement for CQC registration where a provider carries on a regulated activity.
Voluntary standards and professional registers
The Joint Council for Cosmetic Practitioners promotes competence and standards across the aesthetics industry, and maintains a voluntary register for eligible cosmetic practitioners. The Professional Standards Authority accredits qualifying registers, but voluntary registration with the Joint Council for Cosmetic Practitioners will not be a substitute for statutory professional regulation or a licence if the law requires one.
Do you need to be regulated by the CQC for aesthetics treatments?
Whether you need registration as an aesthetic practitioner or clinic depends on the activities you provide. Certain surgical procedures and other regulated activities already require it. Many standalone non-surgical cosmetic treatments do not currently require CQC registration solely because they are aesthetic procedures, but may require this under the proposed expansion to cover specified high-risk treatments.
Non-healthcare professionals can treat patients and provide treatments where existing law permits and they have appropriate competence and safeguards. The proposed framework would distinguish lower risk procedures from high risk procedures reserved for specified healthcare professionals, but does not yet exist in law.
The consequences for non-compliance depend on the obligation involved. Existing offences can lead to prosecution, professional investigations or CQC action. Seek advice promptly if your clinic receives a formal enforcement notice or investigation request, as the team at JMW can support you during any investigation and work to mount a suitable defence on your behalf.
What are the principal regulatory risks for aesthetic practices?
Under the current framework and ignoring any proposed licensing regime changes that do not yet apply, there remain several key areas of risk for aesthetics businesses and treatment providers under the law in England and Wales.
Practitioner competence and clinical oversight
An aesthetic practice may face regulatory concerns where staff perform procedures without suitable training, where clinical oversight is unclear or where a registered professional works beyond their competence. High risk procedures require specialist skills and, even when someone belongs to a regulated profession, they may not be able to deliver particular treatments to the necessary standards.
Document who assesses, prescribes, treats and manages complications, particularly when other healthcare professionals supervise aesthetic practitioners, to support clinical governance. The arrangements should reflect the nature of such treatments, and not rely on policies designed for lower risk work.
Prescription-only products, dermal fillers and medical devices
Product sourcing presents a separate regulatory risk from the MHRA, particularly where dermal fillers or injectables are obtained through unfamiliar suppliers. Clinics should establish whether medicines have been obtained through authorised supply chains and whether medical devices meet applicable requirements before using them, and report any concerns. Counterfeit products, unlawful sales and inappropriate use of prescription only medicines can prompt action by the Medicines and Healthcare products Regulatory Agency and other enforcement bodies.
Consent, hygiene and complaints
Inadequate assessment, infection control or record keeping can expose aesthetic providers to claims or disciplinary action, particularly where they result in adverse outcomes. These risks increase if practitioners cannot explain treatment decisions.
Make sure to carefully collect consent records, and have a formal complaints procedure in place so that you can take action against failings where necessary. Having strong emergency arrangements in place will also support clinical governance, and aesthetic plastic surgeons and other specialists should always meet the required hygiene standards.
Advertising and ethical considerations
Advertising creates risks beyond treatment delivery. Under the Committee of Advertising Practice rules, businesses must not advertise prescription-only products to the public, and it is important to note that indirect promotional wording can also breach these rules. Claims about non surgical aesthetic treatments must not mislead patients or exaggerate results, so be careful with advertising language and the use of before and after imagery.
Businesses should check websites, social media, discount campaigns and statements about qualifications for non-compliance, as misleading claims can prompt enforcement.
How can aesthetic practitioners prepare for further regulation?
Although proposals about licensing for non-surgical cosmetic procedures are still under development, there are steps that any treatment provider can take to minimise risk and maintain compliance before any changes are brought into effect.
Review each procedure or treatment you provide separately (rather than treating all non surgical aesthetic work as one category) to identify whether it is currently a regulated activity, whether local registration is needed and whether the government has proposed restricting it to qualified healthcare professionals.
For procedures considered high risk, assess the impact that future CQC oversight would have, and the implications for registration and staffing. Check prescribing permissions, insurance and supervision in your current position to provide context for this investigation, and determine whether you are currently complying with the relevant legislation.
An effective audit of regulatory compliance should cover:
- Patient assessment, consent discussions and patient records.
- Staff training, professional registration and defined clinical oversight.
- Infection control, emergency equipment and complaints procedures.
- Medicines purchasing, storage, batch records and medical devices.
- Record keeping, incident reporting and periodic reviews of clinical governance.
- Websites, advertising, social media and information given about treatment risks.
Keep evidence of decisions and carry out regular reviews, which can both support compliance with existing regulations and prepare you for a new regulatory framework.
If a regulator contacts you about your aesthetic practice, act quickly to establish which authority is involved, what powers it is exercising and what information it requires. Preserve the relevant records and speak to JMW at your earliest opportunity before responding to allegations or attending a formal interview.
Because a concern may relate to products, registration, advertising or patient safety, it is worthwhile to work with legal professionals whose experience covers the full range of regulatory considerations for businesses in the aesthetics industry. JMW's experienced regulatory team can provide tailored support based on your specific circumstances.
What developments should aesthetic providers expect in 2027 and beyond?
The October 2026 consultation closes on 13 January 2027. Following the consultation, the Government will consider the responses before deciding whether to proceed with the proposed regulations, including any amendments to the draft.
Further proposals are expected for local authority licensing of lower risk procedures, including requirements for training, premises standards and insurance. The scope of that licensing regime, its final fees and the treatment of existing practitioners remain subject to further consultation and legislation.
Clinic owners should monitor government and CQC updates, assess how their services could be affected and avoid treating proposed licensing rules as settled law. Contact the experienced team at JMW for advice on any regulations that apply based on the specifics of your practice, and we can keep you updated ahead of any legal changes that come into force.
The proposed regulations would also introduce criminal liability for certain breaches, including carrying on specified regulated activities without CQC registration, or permitting procedures to be undertaken by practitioners who do not meet the prescribed requirements.
Talk to us
At JMW, we advise clinic owners, aesthetic practitioners and healthcare professionals on the regulatory requirements that affect their work. Our solicitors can advise on registration requirements, professional disciplinary investigations and enforcement proceedings, and defend clients facing allegations concerning counterfeit medicines, unlawful product sales, prescribing practices and unlicensed activities.
Learn more about how our aesthetic regulation solicitors can help if your business is facing an investigation or you need advice on new regulations. Alternatively, call JMW on 0345 872 6666 or use our online enquiry form to request a call back at your convenience.
